ENGLISH
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
Reduction in environmental pollution and emissions as waste is reused
Material for insulation purposes
High durability
Easy to store and transport
Simple and low-cost technique
More than 14 communities and 128 families participated
1,725 eco-bricks were recollected
8,000 USD in vouchers for supermarkets were distributed to the families who participated – a huge relief in COVID times
110,350 m2 of waste was recycled
More than 110,350 m2 of constructions will be built
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
Rationalising the use of energy and natural resources and act on the processes in order to optimise and reduceconsumption.
Reducing the production of waste by increasing and promoting recycling and recovering material wheneverpossible.
Ensuring that materials and procedures used don’t present any risk to the health of workers and to the environment.
Making sure that the use of materials, resources and the incorporation of safe and innovative technologies promoteenvironmental protection and minimise the environmental impacts.
Coaching and engaging employees to perform in a conscious and responsible manner, for the importance ofeveryone in guaranteeing product safety and for improving environmental performance.
Implementing good practices in order to comply with applicable legislation and other requirements that will leadto the environmental preservation.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
Four partners have collaborated on an industry-leading recycling approach
Closed-loop economy for PET-based multilayer Green Deal-compliant
Further collaborations are planned to optimize the process harnessing water-based adhesive technology
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
The traceability of the recycled raw materials involved in the manufacture of the film and the management of plastic waste resulting from the production process.
The percentage content of recycled plastic incorporated into the film manufactured over a certain period of analysis, in accordance with the EN 15343 standard.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
Rationalising the use of energy and natural resources and act on the processes to optimise and reduce consumption.
Reducing waste production by increasing and promoting the recycling and recovery of materials whenever possible.
Guaranteeing that the materials and procedures used don’t present any risk to the health of workers and the environment.
Ensuring that the use of materials, resources and the incorporation of safe and innovative technologies promote environmental protection and minimise environmental impacts.
Training and involving employees in conscious and responsible action, given the importance of everyone in ensuring product safety and improving environmental performance.
Implementing good practices in order to comply with applicable legislation and other requirements that lead to environmental preservation.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
Based on annual capacity
“Baseline report on plastic waste,” UNEP, 2020
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
